Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.58 |
| ▸ | APEX1 | P27695 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10082102 | 0.85 | GABRA1 (0.62) | MEN1MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL15413439 | 0.80 | MEN1 (0.55) | MEN1MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL32690150 | 0.80 | MEN1 (0.55) | MEN1MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL2311502 | 0.79 | KDM4E (0.63) | MEN1MAPTKMT2AKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL15413335 | 0.79 | MEN1 (0.54) | MEN1MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL30448074 | 0.78 | UTS2R (0.54) | ALDH1A1CYP3A4CYP2D6HSD17B10 | |
| SCHEMBL10546827 | 0.78 | UTS2R (0.54) | ALDH1A1CYP3A4CYP2D6HSD17B10 | |
| SCHEMBL4342832 | 0.78 | KDM4E (0.53) | MEN1MAPTKMT2AKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL30448693 | 0.77 | UTS2R (0.53) | ALDH1A1CYP3A4CYP2D6HSD17B10 | |
| SCHEMBL17633446 | 0.77 | MEN1 (0.51) | MEN1MAPTKMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197501-B1 | BIOLOGICAL MATERIALS AND USES THEREOF | ANTIKOR BIOPHARMA LTD (GB) | 2024-04-10 | — | — | EP | disclosed |
| US-11202837-B2 | Biological materials and uses thereof | ANTIKOR BIOPHARMA LIMITED (GB) | 2021-12-21 | — | — | US | disclosed |
| US-20170360951-A1 | BIOLOGICAL MATERIALS AND USES THEREOF | ANTIKOR BIOPHARMA LIMITED (GB) | 2017-12-21 | — | — | US | disclosed |
| EP-3197501-A1 | BIOLOGICAL MATERIALS AND USES THEREOF | Antikor Biopharma Limited (GB) | 2017-08-02 | — | — | EP | disclosed |
| CN-106999605-A | Biological material and use thereof | 安迪高生物制药有限公司 | 2017-08-01 | — | — | CN | disclosed |
| WO-2016046574-A1 | BIOLOGICAL MATERIALS AND USES THEREOF | ANTIKOR BIOPHARMA LIMITED (GB) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11202837-B2 | Biological materials and uses thereof | CD47, LNPEP, TIE1 | MEN1 275/4885MAPT 862/4885KMT2A 1039/4885 |
| US-20170360951-A1 | BIOLOGICAL MATERIALS AND USES THEREOF | CD47, LNPEP, TIE1 | MEN1 275/4885MAPT 862/4885KMT2A 1039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.